SY
0009-0000-4611-6453 Employment
-
National Institute of Pharmaceutical Education and Research PhD Schloar2022 - 2027
Education
-
National Institute of Pharmaceutical Education and Research M.S in Pharmaceutical Analysis2018 - 2020
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- Exploring the clinical trials, regulatory insights, and challenges of PROTACs in oncology Save
- Innovative approaches in regulatory affairs: leveraging artificial intelligence and machine learning for efficient compliance and decision-making Save
- Navigating the Trends in USFDA Authorized Generic Approvals (2019--2024): Enhancing Healthcare Accessibility and Affordability Save
- USFDA Warning Letters: An Analysis of Compliance in Over-the-Counter Drug Products (2020--2024) Save
- Unlocking Generic Market Access: A Retrospective Analysis of USFDA Paragraph IV Filings (2020--2024) Save
- Unraveling Trends in USFDAs CDER-Regulated Drug Shortages (2019--2024): Causes, Patterns, and Strategic Insights for the Future Save
- Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India Save
- Enhancing pharmaceutical accessibility: evaluating the impact of competitive generic therapy exclusivity on rapid access of generics into the US market (2019--2024) Save
- A brief assessment of the bioanalytical methods by using LC-MS/MS for the quantitation of melatonin: a potential biomarker for sleep-related disorders Save
- Proactive Approaches to cGMP Compliance: Insights and Key Takeaways from USFDA Warning Letters to Pharmaceutical Industries Between 2019 and 2024 Save